Dr. Hershman on Late Effects of Intermittent ADT for Prostate Cancer Patients
June 23rd 2015Dawn Hershman, MD, Associate Professor Medicine at Columbia University Medical Center, discusses the late-effects of intermittent androgen deprivation therapy (ADT) to continuous ADT in prostate cancer.
Read More
Dr. Hershman on Adherence to Longer Hormonal Therapy
August 1st 2013Dawn L. Hershman, MD, MS, Associate Professor of Medicine and Epidemiology, Leader, Breast Cancer Program, Herbert Irving Comprehensive Cancer Center, Columbia University, discusses the need for adherence with longer hormonal therapy.
Read More